Increased AURKA Gene Copy Number Correlates with Poor Prognosis and Predicts the Efficacy of High-dose Interferon Therapy in Acral Melanoma.

about

Increased AURKA Gene Copy Number Correlates with Poor Prognosis and Predicts the Efficacy of High-dose Interferon Therapy in Acral Melanoma.

Item

http://www.wikidata.org/entity/Q52718113

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Increased AURKA Gene Copy Numb ...... ron Therapy in Acral Melanoma.

@en

Increased AURKA Gene Copy Numb ...... ron Therapy in Acral Melanoma.

@nl

type

Item

label

Increased AURKA Gene Copy Numb ...... ron Therapy in Acral Melanoma.

@en

Increased AURKA Gene Copy Numb ...... ron Therapy in Acral Melanoma.

@nl

prefLabel

Increased AURKA Gene Copy Numb ...... ron Therapy in Acral Melanoma.

@en

Increased AURKA Gene Copy Numb ...... ron Therapy in Acral Melanoma.

@nl

P1476

Increased AURKA Gene Copy Numb ...... ron Therapy in Acral Melanoma.

@en

P2093

Chuanliang Cui

http://www.w3.org/2001/XMLSchema#string

Huan Tang

http://www.w3.org/2001/XMLSchema#string

Huan Yu

http://www.w3.org/2001/XMLSchema#string

Jiayi Yu

http://www.w3.org/2001/XMLSchema#string

Jie Dai

http://www.w3.org/2001/XMLSchema#string

Jun Guo

http://www.w3.org/2001/XMLSchema#string

Junya Yan

http://www.w3.org/2001/XMLSchema#string

Longwen Xu

http://www.w3.org/2001/XMLSchema#string

Lu Si

http://www.w3.org/2001/XMLSchema#string

Meng Ma

http://www.w3.org/2001/XMLSchema#string

P2860

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplification.

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Pembrolizumab versus Ipilimumab in Advanced Melanoma

Phase II Intergroup Trial of Alisertib in Relapsed and Refractory Peripheral T-Cell Lymphoma and Transformed Mycosis Fungoides: SWOG 1108.

Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: a study of 522 consecutive cases.

Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence.

The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion

Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy.

Incidence of noncutaneous melanomas in the U.S.

P304

1267-1276

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7150/JCA.24013

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29675108

http://www.w3.org/2001/XMLSchema#string

P932

5907675

http://www.w3.org/2001/XMLSchema#string